Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Nitrasanata Dharma TbkISX:JECX -3.42%14 Debt-to-EBITDA is 1.66 as of Dec. 2025, which is at its 10-year median of 1.66. GuruFocus rates ISX:JECX with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 479 Healthcare Providers & Services companies, PT Nitrasanata Dharma Tbk ranks better than 58.87% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for PT Nitrasanata Dharma Tbk's Debt-to-EBITDA or its related term are showing as below:
ISX:JECX'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.21 Med: 1.66 Max: 1.81
Current: 1.66
During the past 3 years, the highest Debt-to-EBITDA Ratio of PT Nitrasanata Dharma Tbk was 1.81. The lowest was 1.21. And the median was 1.66.
ISX:JECX's Debt-to-EBITDA is ranked better than 58.87% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 2.18
vs ISX:JECX: 1.66
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
PT Nitrasanata Dharma Tbk Debt-to-EBITDA Related Terms
PT Nitrasanata Dharma Tbk Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Nitrasanata Dharma Tbk Debt-to-EBITDA Chart
PT Nitrasanata Dharma Tbk Annual Data
Trend
Dec23
Dec24
Dec25
Debt-to-EBITDA
1.21
1.81
1.66
PT Nitrasanata Dharma Tbk Semi-Annual Data
Dec23
Dec24
Dec25
Debt-to-EBITDA
1.21
1.81
1.66
ISX:JECX vs HCA, THC, EHC: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, PT Nitrasanata Dharma Tbk's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Nitrasanata Dharma Tbk Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Nitrasanata Dharma Tbk's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PT Nitrasanata Dharma Tbk's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is one times the quarterly (Dec. 2025) EBITDA data.
PT Nitrasanata Dharma Tbk (ISX:JECX) has a Debt-to-EBITDA of 1.66 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PT Nitrasanata Dharma Tbk. This is near median its historical median of 1.66. Over the past decade, PT Nitrasanata Dharma Tbk's Debt-to-EBITDA has ranged from 1.21 to 1.81. According to the industry distribution chart, PT Nitrasanata Dharma Tbk ranks #197 out of 479 companies in the Healthcare Providers & Services industry, placing it in the top 41.1%.
Is PT Nitrasanata Dharma Tbk's Debt-to-EBITDA too high?
PT Nitrasanata Dharma Tbk's current Debt-to-EBITDA of 1.66 is near median its 10-year median of 1.66. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 1.81. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.18. PT Nitrasanata Dharma Tbk's value of 1.66 is 23.9% below this industry median. Based on the distribution chart, PT Nitrasanata Dharma Tbk ranks #197 out of 479 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Nitrasanata Dharma Tbk has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does PT Nitrasanata Dharma Tbk's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Nitrasanata Dharma Tbk ranks #197 out of 479 companies for Debt-to-EBITDA. This puts PT Nitrasanata Dharma Tbk in the upper half of its industry. The industry median Debt-to-EBITDA is 2.18. PT Nitrasanata Dharma Tbk's value of 1.66 is 23.9% below this benchmark. Historically, PT Nitrasanata Dharma Tbk's own Debt-to-EBITDA has ranged from 1.21 to 1.81 over the past decade. While the company's 10-year median is 1.66 vs. the industry median of 2.18, PT Nitrasanata Dharma Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.18, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Nitrasanata Dharma Tbk's current Debt-to-EBITDA of 1.66 is 23.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PT Nitrasanata Dharma Tbk. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Nitrasanata Dharma Tbk's current Debt-to-EBITDA is 1.66, which is near median its own 10-year median of 1.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Nitrasanata Dharma Tbk stock overvalued right now?
PT Nitrasanata Dharma Tbk (ISX:JECX) has a current Debt-to-EBITDA of 1.66. The current Debt-to-EBITDA is 1.66, which is near median its 10-year median of 1.66 and 23.9% below the Healthcare Providers & Services industry median of 2.18. PT Nitrasanata Dharma Tbk's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For PT Nitrasanata Dharma Tbk (ISX:JECX), the current Debt-to-EBITDA is 1.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Nitrasanata Dharma Tbk, commercially operating as JEC Eye Hospitals & Clinics, is a specialized healthcare provider focused on eye care services. Its service offerings include Cataract, Laser Vision Correction, Corneal Services, Vitreoretinal Services, Glaucoma Services, etc.
14GF Score
Get the complete analysis for ISX:JECX
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:JECX has been successfully added to your 
